Ingelheim, Germany Saturday, January 18, 2025, 11:00 Hrs [IST] ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking ... along with the integration of a new animal health business bought from Sanofi ...

Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the Guardant360 CDx liquid biopsy as a companion diagnostic for ...

With 53,000 employees, it operates in over 130 markets, focusing on Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Established in 2003, Boehringer Ingelheim India ...

The Western Canadian Association of Bovine Practitioners (WCABP) and Boehringer Ingelheim Animal Health Canada Inc. have ...

The MoU includes the implementation of formal stroke protocols for RED.Health ambulances and the ... one of tens of thousands against GSK, Boehringer Ingelheim and other pharmaceutical companies ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were ...